Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-58,493
Closed -$1.53M 3199
2025
Q3
$1.53M Buy
58,493
+26,870
+85% +$666K ﹤0.01% 1743
2025
Q2
$712K Buy
+31,623
New +$649K ﹤0.01% 2002
2025
Q1
Sell
-10,660
Closed -$226K 2858
2024
Q4
$226K Buy
+10,660
New +$234K ﹤0.01% 2316
2023
Q3
Sell
-27,405
Closed -$500K 2445
2023
Q2
$500K Buy
+27,405
New +$475K ﹤0.01% 1988
2020
Q1
Sell
-31,935
Closed -$533K 1852
2019
Q4
$533K Buy
+31,935
New +$512K ﹤0.01% 1145
2019
Q3
Sell
-181,540
Closed -$2.72M 1794
2019
Q2
$2.72M Sell
181,540
-178,240
-50% -$2.55M 0.02% 682
2019
Q1
$5.17M Buy
359,780
+206,310
+134% +$3.04M 0.05% 461
2018
Q4
$2.19M Buy
+153,470
New +$2.41M 0.02% 699

Other funds holding IX

Marshall Wace's IX Position: Q4 2025 in Review

Marshall Wace sold out of ORIX (IX) in Q4 2025, closing a stake of 58,493 shares — an estimated $1.53M sold.

Marshall Wace first reported a position in IX in Q4 2018 and held it in 8 quarters. The position peaked at $5.17M in Q1 2019. 240 funds tracked by Wall St. Rank hold IX as of Q4 2025.

  • Marshall Wace reported no remaining ORIX position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 58,493 ORIX shares in Q4 2025, an estimated $1.53M.
  • Marshall Wace first reported a position in ORIX in Q4 2018 and held it in 8 quarters.
  • Marshall Wace's ORIX position peaked at $5.17M in Q1 2019.
  • 240 funds tracked by Wall St. Rank held ORIX as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.